.
  • NIFTY 25,285.35 +103.55 (+0.41%)
  • SENSEX 82,500.82 +328.72 (+0.40%)
 
BSE
NSE

Friday, October 10, 2025 , BSE Sensex : 82,500.82 82,500.82(0.40%) , Adani Ports : 1,408.95 1,408.95(0.90%) , Asian Paints : 2,340.30 2,340.30(0.20%) , Axis Bank : 1,180.10 1,180.10(1.08%) , Bajaj Finance : 1,023.70 1,023.70(-0.05%) , Bajaj Finserv : 2,004.30 2,004.30(-0.46%) , Bharat Electron : 413.25 413.25(0.94%) , Bharti Airtel : 1,939.60 1,939.60(-0.09%) , Eternal Ltd : 348.35 348.35(0.87%) , HCL Technologies : 1,494.70 1,494.70(0.56%) , HDFC Bank : 980.90 980.90(0.38%) , Hind. Unilever : 2,529.10 2,529.10(0.46%) , ICICI Bank : 1,380.65 1,380.65(0.32%) , Infosys : 1,514.25 1,514.25(0.32%) , ITC : 402.80 402.80(0.73%) , Kotak Mah. Bank : 2,149.55 2,149.55(0.21%) , Larsen & Toubro : 3,783.30 3,783.30(0.37%) , M & M : 3,454.55 3,454.55(0.34%) , Maruti Suzuki : 16,276.05 16,276.05(1.87%) , NTPC : 339.50 339.50(1.07%) , Power Grid Corpn : 289.15 289.15(1.05%) , Reliance Industr : 1,381.95 1,381.95(0.29%) , SBI : 880.75 880.75(2.16%) , Sun Pharma.Inds. : 1,670.85 1,670.85(0.75%) , Tata Motors : 679.05 679.05(-0.15%) , Tata Steel : 173.80 173.80(-1.47%) , TCS : 3,028.40 3,028.40(-1.10%) , Tech Mahindra : 1,457.25 1,457.25(-0.62%) , Titan Company : 3,531.30 3,531.30(-0.54%) , Trent : 4,689.55 4,689.55(0.52%) , UltraTech Cem. : 12,274.25 12,274.25(0.67%) ,

Nifty 50 : 25,285.35 103.55(0.41%) , Adani Enterp. : 2,550.90 8.50(0.33%) , Adani Ports : 1,409.40 13.80(0.99%) , Apollo Hospitals : 7,681.00 -14.00(-0.18%) , Asian Paints : 2,340.20 3.80(0.16%) , Axis Bank : 1,180.40 13.00(1.11%) , Bajaj Auto : 8,946.50 136.50(1.55%) , Bajaj Finance : 1,023.85 -0.25(-0.02%) , Bajaj Finserv : 2,004.30 -10.30(-0.51%) , Bharat Electron : 413.50 4.15(1.01%) , Bharti Airtel : 1,939.90 -2.10(-0.11%) , Cipla : 1,561.80 48.70(3.22%) , Coal India : 384.50 1.15(0.30%) , Dr Reddy's Labs : 1,264.40 18.30(1.47%) , Eicher Motors : 6,965.00 68.50(0.99%) , Eternal Ltd : 348.30 2.80(0.81%) , Grasim Inds : 2,811.00 0.40(0.01%) , HCL Technologies : 1,495.50 9.00(0.61%) , HDFC Bank : 980.90 3.80(0.39%) , HDFC Life Insur. : 747.30 -7.05(-0.93%) , Hind. Unilever : 2,528.90 11.30(0.45%) , Hindalco Inds. : 773.95 -0.15(-0.02%) , ICICI Bank : 1,380.30 4.10(0.30%) , Infosys : 1,514.90 5.60(0.37%) , Interglobe Aviat : 5,735.00 10.50(0.18%) , ITC : 402.80 2.90(0.73%) , Jio Financial : 308.15 0.80(0.26%) , JSW Steel : 1,167.80 -7.40(-0.63%) , Kotak Mah. Bank : 2,150.10 5.50(0.26%) , Larsen & Toubro : 3,784.00 14.80(0.39%) , M & M : 3,454.90 12.00(0.35%) , Maruti Suzuki : 16,265.00 280.00(1.75%) , Max Healthcare : 1,156.40 0.60(0.05%) , Nestle India : 1,199.50 11.70(0.99%) , NTPC : 339.70 3.85(1.15%) , O N G C : 246.34 2.95(1.21%) , Power Grid Corpn : 289.15 3.00(1.05%) , Reliance Industr : 1,381.70 3.90(0.28%) , SBI : 880.65 18.55(2.15%) , SBI Life Insuran : 1,810.40 0.60(0.03%) , Shriram Finance : 665.05 -4.00(-0.60%) , Sun Pharma.Inds. : 1,670.90 12.40(0.75%) , Tata Consumer : 1,126.50 8.50(0.76%) , Tata Motors : 678.95 -2.15(-0.32%) , Tata Steel : 173.86 -2.56(-1.45%) , TCS : 3,028.30 -33.40(-1.09%) , Tech Mahindra : 1,457.20 -9.40(-0.64%) , Titan Company : 3,531.90 -18.70(-0.53%) , Trent : 4,691.10 30.20(0.65%) , UltraTech Cem. : 12,281.00 89.00(0.73%) , Wipro : 248.70 2.30(0.93%) , Friday, October 10, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
25-Sep-2025     09:30
Lupin gains after USFDA clears HIV drug for tentative launch

The drug is the generic version of Biktarvy Tablets (50 mg/200 mg/25 mg), marketed by Gilead Sciences, Inc., and is indicated for the treatment of HIV infection in adults and pediatric patients weighing at least 25 kg. Lupin's version of the drug will be manufactured at its facility in Nagpur, India.

According to IQVIA data for the 12 months ending July 2025, Biktarvy had estimated annual sales of $16,237 million in the U.S. market.

This tentative approval marks another milestone in Lupin's strategy to expand its complex generics portfolio in the U.S. market. The approval paves the way for Lupin to launch the drug upon patent expiry or final regulatory clearance.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

The company's consolidated net profit jumped 52.13% to Rs 1,219.03 crore on an 11.78% increase in income from operations to Rs 6,163.75 crore in Q1 FY26 over Q1 FY25.

Powered by Capital Market - Live News